Pickering Grant's Form 4 filing
Vaxcyte, Inc. (PCVX) · filed Sep 28, 2022
- Accession no.
- 0001209191-22-051492
- Filed
- Sep 28, 2022
- Trade date
- Sep 26, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $247.2K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001209191-22-051682 (Sep 30, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pickering GrantCIK 0001258693 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2022 | Common Stock | SSaleDisposed | −4,773 | $24.69F2 | −$117,845.37 | 158,057 | Indirect | |
| Sep 26, 2022 | Common Stock | SSaleDisposed | −227 | $25.30F4 | −$5,743.1 | 157,830 | Indirect | |
| Sep 26, 2022 | Common Stock | SSaleDisposed | −4,681 | $24.68F5 | −$115,527.08 | 158,149 | Indirect | |
| Sep 26, 2022 | Common Stock | SSaleDisposed | −319 | $25.28F7 | −$8,064.32 | 157,830 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted-average price. The shares were sold at prices ranging from $24.215 to $25.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted-average price. The shares were sold at prices ranging from $25.26 to $25.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted-average price. The shares were sold at prices ranging from $24.23 to $25.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported is a weighted-average price. The shares were sold at prices ranging from $25.25 to $25.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.